Symbicort Powder (Budesonide / Formoterol Fumarate Dihydrate) – Patient Information (Australia)
Symbicort Powder contains two medicines: budesonide (a corticosteroid) and formoterol fumarate dihydrate (a long-acting bronchodilator). It is used to help control breathing problems caused by asthma and chronic obstructive pulmonary disease (COPD) in appropriate patients. This page provides easy-to-understand information about how Symbicort works, when it is used, how to take it, and what to consider for safety and interactions.
Brand names and device types may vary (e.g., different inhaler devices). Always follow the specific instructions provided with your product and your healthcare professional’s advice.
Quick Summary
- What it is: An inhaled combination medicine containing budesonide + formoterol.
- What it does: Reduces airway inflammation (budesonide) and helps keep airways open (formoterol).
- Common uses: Asthma control; COPD symptom management (for eligible patients).
- How it’s taken: Inhaled via a dry powder inhaler (DPI) as directed.
- Timing: Often taken regularly every day; some regimens allow symptom relief using the same inhaler in certain asthma treatment plans.
- Key safety points: Do not stop suddenly; monitor for side effects such as oral thrush, tremor, palpitations, or worsening symptoms.
Basic Product Information
| Feature | Information |
|---|---|
| Medicine (active ingredients) | Budesonide / formoterol fumarate dihydrate |
| Dosage form | Inhalation powder (dry powder inhaler form) |
| Type of medicines | Inhaled corticosteroid (ICS) + long-acting beta2-agonist (LABA) |
| Main purpose | Control inflammation and improve airflow in the lungs |
| Typical use frequency | Usually twice daily for ongoing control (varies by asthma/COPD plan) |
| Who it is for | People with asthma or COPD who have been assessed as needing ICS/LABA therapy |
How Symbicort Works (Mechanism of Action)
Symbicort is a combination of two medicines that act in different ways to improve breathing:
-
Budesonide (inhaled corticosteroid)
Helps reduce inflammation in the airways. It works by decreasing inflammatory chemicals and thickening/swelling of airway tissue, leading to fewer symptoms and fewer flare-ups over time. -
Formoterol fumarate dihydrate (long-acting beta2-agonist)
Relaxes the smooth muscle around the airways to open the air passages. This reduces bronchoconstriction and improves airflow. Formoterol has a relatively fast onset of action compared with some other LABAs, which can be useful in certain asthma regimens.
Together, the two components provide both long-term control (via budesonide) and airway opening (via formoterol), which helps reduce symptoms such as wheeze, shortness of breath, chest tightness, and coughing.
Indications and When It May Be Used
Symbicort may be used for:
- Asthma: To improve and maintain control of asthma symptoms and reduce the risk of exacerbations for people who need an ICS/LABA combination.
- COPD: For symptom management in patients with COPD who require regular bronchodilator and anti-inflammatory therapy as assessed by their clinician.
Important: Symbicort is not a substitute for emergency treatment. If you experience severe breathing difficulty, use your emergency plan and seek urgent medical care.
Typical Use and Timing
How Symbicort should be taken depends on your personal treatment plan and the severity/type of your condition.
Asthma
Common regimens include:
- Maintenance (regular prevention): Typically taken twice daily.
- Single inhaler approach in some patients: In certain asthma plans, some doses may be used both for maintenance and relief. This approach depends on local guidance and your doctor’s instructions.
COPD
For COPD, Symbicort is generally used as maintenance therapy, often twice daily, in combination with other treatments if appropriate.
Consistency matters: Because budesonide works on airway inflammation, regular dosing is important for best control.
Dosing (General Guidance)
Dose varies by age, diagnosis (asthma vs COPD), symptom control, and the specific strength of the inhaler. Always use the dose prescribed for you and do not change it without medical advice.
General principles commonly used in practice:
- Lowest effective dose: Many patients are maintained on the lowest dose that controls symptoms.
- Adjustments over time: If symptoms are well controlled, clinicians may consider step-down therapy; if symptoms are not controlled, a review of technique and adherence is often done first.
- Do not stop abruptly: Sudden cessation may lead to worsening symptoms.
How to use the device correctly is crucial. Incorrect technique can reduce the amount of medicine reaching your lungs and increase the chance of side effects (such as mouth/throat irritation).
How to Use Symbicort Powder (Practical Tips)
Because Symbicort comes in a powder form, proper inhalation technique is key. The exact steps depend on your specific inhaler device, so always follow the instruction leaflet included with your product.
General inhalation tips
- Use the device as instructed: Do not breathe out into the inhaler.
- Inhale strongly and steadily: DPI medicines rely on your inspiratory flow to deliver powder to the lungs.
- Hold your breath briefly after inhalation if your device instructions recommend it.
- Don’t “double-dose” if you miss a dose—follow your plan for missed doses or ask your pharmacist.
Reduce mouth irritation and thrush
Budesonide can increase the risk of oral thrush (fungal infection in the mouth) and hoarseness. To reduce this risk:
- Rinse your mouth with water after each dose.
- Spit out the rinse water (do not swallow).
- If you wear dentures, clean them as directed.
Pharmacokinetics (How the Body Handles the Medicine)
Pharmacokinetics describes how the body absorbs, distributes, metabolises, and eliminates the medicine.
Absorption
- Inhaled delivery means most of the medicine is intended to deposit in the airways rather than being swallowed.
- Some portion may still reach the throat and be swallowed, but the main effect comes from lung deposition.
Distribution
- After absorption, budesonide and formoterol distribute into tissues. Their clinical effect is primarily local in the lungs, though systemic absorption can occur.
Metabolism
- Budesonide is extensively metabolised, mainly in the liver, resulting in metabolites with less activity than the parent drug.
- Formoterol is also metabolised, and the body clears it over time.
Elimination
- Both medicines and their metabolites are eliminated mainly via urine and/or other routes as determined by metabolism.
Because Symbicort is inhaled, drug levels in the body may be lower than with some oral medicines. However, systemic side effects can still occur, especially at higher doses or if the inhalation technique is poor.
Food Interactions
Because Symbicort is inhaled, food interactions are generally minimal. The medicine acts locally in the lungs, and there is no common need to take it with or without meals.
- To further reduce side effects: rinsing your mouth after inhalation is more important than meal timing.
- If you notice reflux or irritation, your clinician may advise lifestyle adjustments or additional treatment.
Alcohol and Medicine Interactions
Alcohol
There is typically no direct interaction between alcohol and Symbicort that is widely established. However:
- Alcohol can affect sleep and overall asthma/COPD control in some people.
- Heavy alcohol intake may increase the risk of dehydration or worsen breathing in some individuals.
If you’re unsure, ask your pharmacist—especially if you have liver disease or take multiple medicines.
Medicine interactions
Some medicines may affect Symbicort’s safety and effectiveness. Tell your doctor or pharmacist about all medicines you take, including:
- Beta-blockers (including some eye drops): may reduce bronchodilator effects and can worsen breathing in susceptible people.
- Other inhaled bronchodilators or asthma/COPD medicines: may add to effects on heart rate or tremor.
- Medicines that affect the liver enzymes (such as certain antibiotics or antifungals): may alter levels of budesonide or formoterol.
- Diuretics (“water tablets”): when combined with beta-agonists, may contribute to low potassium levels in rare cases.
- Other medicines that can affect potassium or heart rhythm: may increase the risk of rhythm changes.
Always read the labels of new medicines and check with a pharmacist if you’re starting something new—especially in people with heart conditions, irregular heartbeat, or significant electrolyte issues.
Safety Profile: Common and Serious Side Effects
Like all medicines, Symbicort can cause side effects. Many are manageable, and careful inhaler technique can reduce some risks.
Common side effects
- Oral thrush (white patches in mouth) and hoarseness
- Throat irritation
- Tremor or shakiness
- Headache
- Palpitations (awareness of heartbeat)
- Muscle cramps (less common)
When to seek urgent help
Get urgent medical assistance if you experience:
- Severe breathing difficulty or symptoms that rapidly worsen
- Signs of an allergic reaction (swelling of face/lips, hives, wheezing)
- Chest pain, fainting, or significant irregular heartbeat
- Symptoms of high-dose beta-agonist effects such as severe tremor or marked palpitations
Long-term considerations
- Inhaled steroids can, at higher doses or with long-term use, contribute to systemic effects (risk varies). Your clinician will aim for the lowest effective dose.
- If you’re at risk of bone thinning, diabetes, cataracts, or glaucoma, your healthcare team may monitor you.
Practical Use Tips for Better Results
- Check inhaler technique regularly: Many “treatment failures” are due to incorrect technique.
- Don’t skip doses: Missing doses can reduce inflammation control (especially the budesonide component).
- Use a spacer only if your device supports it: Symbicort powder is a DPI and typically does not use spacers; follow your specific instructions.
- Rinse and spit after each dose.
- Keep track of symptoms: If you frequently need additional reliever medicine or symptoms wake you at night, ask for a review.
- Store properly: Keep the inhaler dry and away from excessive heat or moisture, as powder products can be affected.
Alternative Options
If Symbicort isn’t suitable or if your symptoms aren’t controlled, there are other inhaled therapies that clinicians may consider. Alternatives can include:
- Other ICS/LABA combinations (different strengths or device types)
- Inhaled corticosteroid alone in selected asthma patients (not usually for COPD symptom control without a bronchodilator plan)
- Different reliever strategies depending on your condition (your clinician may adjust your overall inhaler plan)
- For COPD: additional or alternative bronchodilators (e.g., LAMA or other combinations) may be considered
Device fit matters: Some people respond better to different inhaler devices depending on hand strength, breathing flow, and technique.
Market and Legal Context for Australia
In Australia, medicines like Symbicort are regulated by the Therapeutic Goods Administration (TGA). Inhaled corticosteroids and bronchodilators are widely used for asthma and COPD management under established clinical practice and product labelling requirements.
Pharmacy supply: Availability, prescribing requirements, and patient eligibility depend on the product, strength, and local regulatory classification at the time of supply. Always confirm product details shown on the listing and follow any purchasing and dispensing requirements associated with your order.
Clinical responsibility: Asthma and COPD require ongoing assessment. Regular reviews help ensure correct dosing, technique, and response to treatment.
Recent Guidance and Clinical Practice Notes (Australia)
Clinical management of asthma and COPD in Australia commonly follows guidance from professional bodies such as Asthma Australia and the National Asthma Council Australia (NAC), and for COPD often aligns with recommendations from respiratory guidelines used by clinicians.
Key common themes in recent practice include:
- Personalised control: Treatment is adjusted based on symptom control and exacerbation history.
- Inhaler technique review: Checking technique and adherence is often a first step before escalating doses.
- Reducing exacerbations: Consistent use of controller therapy (including ICS) is emphasised.
- Safety monitoring: Clinicians consider side effects such as thrush, hoarseness, and systemic steroid risks.
For the most up-to-date regimen details (including any “maintenance and reliever” strategy in asthma), follow the plan provided by your healthcare professional and the instructions specific to your Symbicort product.
Delivery and Availability
Online pharmacies in Australia may offer home delivery where permitted. Availability can depend on stock levels, device/strength selection, and supply arrangements with wholesalers and manufacturers.
- In-stock status: Some strengths or device formats may sell out temporarily.
- Delivery timeframes: Vary by location and shipping method (standard vs express).
- Packaging: Products are typically dispatched in manufacturer-approved packaging with patient information included.
Check the product listing for estimated delivery times, postage options, and any handling requirements.
FAQ: Symbicort Powder
1) Is Symbicort a reliever or a preventer?
Symbicort is primarily a controller medicine because it includes budesonide, which reduces inflammation. It also contains formoterol, which can help relieve symptoms in certain regimens. Whether it is used for relief depends on your exact treatment plan.
2) How long does it take to work?
Formoterol can provide symptom improvement relatively quickly for many people. However, budesonide works over days to weeks to improve long-term control and reduce flare-ups. If symptoms don’t improve or you’re getting worse, seek a review.
3) What if I miss a dose?
If you miss a scheduled dose, take it as soon as you remember unless it’s close to the next dose. Do not double up. If you’re unsure, ask your pharmacist for advice based on your regimen.
4) Should I rinse my mouth after using Symbicort?
Yes. Rinsing your mouth and spitting out the water after each dose helps reduce the risk of thrush and hoarseness.
5) Can I use Symbicort with other asthma or COPD medicines?
Often, yes—depending on your treatment plan. However, some medicines can interact or change side effects (for example, certain beta-blockers). Always tell your pharmacist about all medicines you use.
6) Are there any food or alcohol restrictions?
Food interactions are generally minimal. Alcohol does not typically have a direct interaction, but heavy alcohol intake may worsen breathing or overall health. If you have liver disease or other risk factors, seek individual advice.
7) What side effects should I watch for?
Common issues include thrush, hoarseness, tremor, headache, and palpitations. Seek urgent help for severe breathing difficulty, signs of allergy, chest pain, fainting, or significant irregular heartbeat.
8) Can Symbicort affect my heart rate?
Because formoterol is a beta2-agonist, some people may experience palpitations or tremor. If you have heart conditions or irregular heartbeat history, discuss with a clinician before starting or changing therapy.
9) How do I know my inhaler technique is correct?
Incorrect technique is common. If you can’t get symptoms controlled, review steps with a pharmacist or nurse. Signs of technique problems include difficulty inhaling the powder, coughing immediately after inhalation, or frequent need for additional reliever treatment.
10) Is it safe to stop Symbicort suddenly?
Usually, it’s not recommended to stop suddenly without medical guidance. If you want to stop or reduce treatment, a gradual plan may be needed.
Need More Help?
If you have questions about your Symbicort Powder dose schedule, inhaler technique, or interactions with your other medicines, speak with a pharmacist. They can help you understand the product instructions and support safe, effective use.

